Senior insider sale
Chief Financial Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$708.3K
8.59K shares
What this filing means
ALI ASIF plans to sell 8.59K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $708.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/21/2026ACC: 0001104659-26-005435
Officer· Chief Financial Officer
Since Apr 2022
8.59K
Shares to sell
$708.3K
Approx. market value
8.59K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Services Rendered
1/20/2026
8.59KTotal acquired8.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/20/2026 | Restricted stock vesting under a registered plan Services Rendered | 8.59K | — |
| Total | 8.59K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
8.59K
Market value
$708.3K
1/20/2026
Total
Units
8.59K
Value
$708.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/20/2026 | 8.59K | $708.3K | NASDAQ | Planned |
| Total | 8.59K | $708.3K | ||